Belluscura gets green light in China
By HME News Staff
Updated 9:25 AM CST, Wed December 20, 2023
LONDON and PLANO, Texas – Belluscura has received approval from the National Medical Products Administration to distribute the X-PLOR portable oxygen concentrator in China. China is part of the licensed territory covered by the exclusive license agreement with InnoMax Medical Device Technologies announced in August 2023. "We are delighted to have received approval in China which has taken over approximately 10 months,” said Bob Rauker, CEO. “This enables us to launch sales into China with immediate effect. With our arrangement with InnoMax in place, we are confident that we can now deliver on the significant potential for our products in this large and growing market.” With this approval secured, Belluscura has now entered into negotiations with several distributors in China. Belluscura has now concluded three sizeable registrations within the Asian market: Hong Kong in September, Singapore in December and now China. Belluscura estimates the oxygen concentrator market size for the Asia Pacific region is expected to grow to nearly $1 billion in just six years.
Comments